These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 10698497

  • 1. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497
    [Abstract] [Full Text] [Related]

  • 2. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 1996 Feb 01; 12(3):537-46. PubMed ID: 8637710
    [Abstract] [Full Text] [Related]

  • 3. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.
    Biochemistry; 1996 Sep 17; 35(37):12070-6. PubMed ID: 8810912
    [Abstract] [Full Text] [Related]

  • 4. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ.
    Clin Cancer Res; 2000 Nov 17; 6(11):4265-71. PubMed ID: 11106242
    [Abstract] [Full Text] [Related]

  • 5. Functional properties of WT1.
    Haber DA, Englert C, Maheswaran S.
    Med Pediatr Oncol; 1996 Nov 17; 27(5):453-5. PubMed ID: 8827073
    [Abstract] [Full Text] [Related]

  • 6. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF.
    Oncogene; 1995 Feb 02; 10(3):415-22. PubMed ID: 7845666
    [Abstract] [Full Text] [Related]

  • 7. Wilms tumor and the WT1 gene.
    Lee SB, Haber DA.
    Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525
    [Abstract] [Full Text] [Related]

  • 8. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
    Huang RP, Darland T, Okamura D, Mercola D, Adamson ED.
    Oncogene; 1994 May 10; 9(5):1367-77. PubMed ID: 8152797
    [Abstract] [Full Text] [Related]

  • 9. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C, McGee SB, Cornwell MM.
    Cell Growth Differ; 1999 Jun 10; 10(6):377-86. PubMed ID: 10392899
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM, Saunders GF.
    Anticancer Res; 1996 Jun 10; 16(2):621-6. PubMed ID: 8687106
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of Wilms' tumor genes.
    Hirose M.
    J Med Invest; 1999 Aug 10; 46(3-4):130-40. PubMed ID: 10687307
    [Abstract] [Full Text] [Related]

  • 15. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X, Xing G, Saunders GF.
    Anticancer Res; 1999 Aug 10; 19(3A):1641-8. PubMed ID: 10470095
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG.
    Cell Growth Differ; 1997 Feb 10; 8(2):133-43. PubMed ID: 9040935
    [Abstract] [Full Text] [Related]

  • 17. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
    Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA.
    Cancer Res; 1995 Oct 15; 55(20):4540-3. PubMed ID: 7553624
    [Abstract] [Full Text] [Related]

  • 18. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ, Wang ZY, Deuel TF, Xu YH.
    Biochem Biophys Res Commun; 1999 Jan 08; 254(1):197-9. PubMed ID: 9920757
    [Abstract] [Full Text] [Related]

  • 19. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J, Nau MM, Yeh JC, Allegra CJ, Chu E, Wright JJ.
    Clin Cancer Res; 2000 Sep 08; 6(9):3522-9. PubMed ID: 10999739
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM, Hinkes MT, Bernfield M, Rauscher FJ.
    Oncogene; 1996 Oct 17; 13(8):1789-99. PubMed ID: 8895526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.